- 1 551
- 1 616 793
Touch Medical Media Services
United Kingdom
Приєднався 31 бер 2013
Touch Medical Media - educating physicians on a fully global scale since 2005!
We make positive changes to clinical practice, with the ultimate objective of improving patient and community health.
Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinion to support best practice for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates
Home of:
- touchONCOLOGY
- touchENDOCRINOLOGY
- touchOPHTHALMOLOGY
- touchNEUROLOGY
- touchCARDIOLOGY
- touchINFECTIOUSDISEASES
- touchIMMUNOLOGY
- touchRESPIRATORY
- touchHAEMATOLOGY
- touchDERMATOLOGY
This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
We make positive changes to clinical practice, with the ultimate objective of improving patient and community health.
Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinion to support best practice for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates
Home of:
- touchONCOLOGY
- touchENDOCRINOLOGY
- touchOPHTHALMOLOGY
- touchNEUROLOGY
- touchCARDIOLOGY
- touchINFECTIOUSDISEASES
- touchIMMUNOLOGY
- touchRESPIRATORY
- touchHAEMATOLOGY
- touchDERMATOLOGY
This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Navigating diagnosis, monitoring, and early treatment in achondroplasia: Multidisciplinary insights
In this activity, a multidisciplinary team of specialist obstetricians and pediatricians, along with a parent of a child with achondroplasia, share their insights on managing achondroplasia. They discuss the coordination of specialist referrals, the importance of early recognition and treatment initiation, and the impact of pharmacotherapies on children with the condition.
Find out more here: touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in-achondroplasia/
Or
Register now to stay informed: www.touchendocrinology.com/your-free-10-minutes-at-a-time-medical-education/
This activity is funded by an independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME.
#MedEd
#achondroplasia
#BoneDisorders
#Endocrinology
#PediatricEndocrinology
#obstetricians
#skeletaldysplasia
#multidisciplinaryteam
Find out more here: touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in-achondroplasia/
Or
Register now to stay informed: www.touchendocrinology.com/your-free-10-minutes-at-a-time-medical-education/
This activity is funded by an independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME.
#MedEd
#achondroplasia
#BoneDisorders
#Endocrinology
#PediatricEndocrinology
#obstetricians
#skeletaldysplasia
#multidisciplinaryteam
Переглядів: 37
Відео
Advanced urothelial carcinoma: Expert guidance to navigate an evolving therapeutic landscape
Переглядів 517 годин тому
Get an update on the latest developments in the treatment of advanced urothelial carcinoma, including the latest guideline recommendations, supporting clinical data and factors to guide decision making in clinical practice, with Prof. Thomas Powles. Watch here: touchoncologyime.org/advanced-urothelial-carcinoma-expert-guidance-to-navigate-an-evolving-therapeutic-landscape/ Or Register now to st...
Clinical decision making with immunotherapies in advanced or recurrent endometrial cancer
Переглядів 3514 днів тому
In this activity, a gynaecological oncologist considers the expanding role of molecular classification in endometrial cancer and provides an update on the use of immune checkpoint inhibitors to treat patients with advanced or recurrent disease, including key guideline recommendations, supporting data and considerations for clinical practice. Watch now: touchoncologyime.org/immunotherapy-in-endo...
Optimizing management of bronchiolitis obliterans syndrome: Current strategies, future directions
Переглядів 6521 день тому
Explore the pathogenesis, diagnostic strategies and current and emerging treatments for BOS in lung transplant recipients in this touchEXPERT OPINIONS. Join the discussion with Dr Michael Perch, Dr Howard J Huang & Dr Aldo Iacono here: touchrespiratoryime.org/eo-management-of-bos/ or Register today to stay informed: www.touchrespiratory.com/your-free-10-minutes-at-a-time-medical-education/ This...
Harnessing the power of precision medicine for the treatment of colorectal cancer
Переглядів 7021 день тому
Join us as two experts in gastrointestinal oncology respond to questions from the oncology community on the role of biomarker-targeted therapies in personalizing treatment decisions in patients with CRC. In Module 1, they explore biomarker-led patient identification, current treatment options and considerations for anti-EGFR rechallenge. In Module 2, they discuss the role of biomarkers in treat...
Harnessing the power of precision medicine for the treatment of colorectal cancer
Переглядів 1042 місяці тому
Join us as two experts in gastrointestinal oncology respond to questions from the oncology community on the role of biomarker-targeted therapies in personalizing treatment decisions in patients with CRC. In Module 1, they explore biomarker-led patient identification, current treatment options and considerations for anti-EGFR rechallenge. In Module 2, they discuss the role of biomarkers in treat...
Current treatments and unmet needs in limited-stage small cell lung cancer
Переглядів 622 місяці тому
Join us for a quick-fire interview on limited-stage small cell lung cancer (LS-SCLC) with expert thoracic oncologist, Dr Anne Chiang. Learn about the role of chemoradiotherapy, prophylactic cranial irradiation and surgery in treating LS-SCLC, as well as the remaining unmet treatment needs. Watch now: touchoncologyime.org/focus-current-treatments-and-unmet-needs-in-ls-sclc/ Register today to sta...
Multidisciplinary perspectives on management of agitation in Alzheimer’s dementia
Переглядів 762 місяці тому
Join a multidisciplinary team of specialists and a former care partner as they share insights on the impact and behavioral symptoms of agitation in Alzheimer’s dementia. Gain valuable perspectives on diagnosis criteria and best practice management. Discover more about the prevalence, impact, and management of agitation in Alzheimer’s dementia: touchneurologyime.org/mdt-perspectives-on-managemen...
Elevating the role of basal insulin therapy in T2D management
Переглядів 622 місяці тому
Join renowned endocrinologists Dr Viswanathan Mohan and Dr Alice Cheng as they address enquiries from the endocrinology and primary care communities regarding practical considerations for basal insulin therapy in patients with T2D. Explore the current and future applications of continuous glucose monitoring, fixed-ratio combinations, and once-weekly basal insulin regimens. Learn more: touchendo...
What’s on the horizon to tackle unmet needs in recurrent/metastatic SCCHN?
Переглядів 383 місяці тому
Hear insights from experts: Dr Aline Chaves, Prof. Makoto Tahara and Dr Ranee Mehra explore the rationale and latest data for immunotherapy-based and targeted treatments in development for recurrent/metastatic SCCHN. Watch now: touchoncologyime.org/future-treatment-of-recurrent-metastatic-scchn/ This activity is funded by an independent medical education grant from Seagen Inc. and Genmab US, In...
Emerging second-line treatment approaches in advanced NSCLC: The role of ADCs
Переглядів 903 місяці тому
Lung cancer expert Dr Rebecca Heist highlights the role of antibody-drug conjugates in the treatment of patients with advanced NSCLC, including their structure and mechanistic rationale, the latest clinical trial data, and key considerations for their application in the clinic. Join the conversation and stay informed - touchoncologyime.org/emerging-second-line-treatment-approaches-in-advanced-n...
Expert insights in food allergy: Considerations for diagnosis & management in primary care & beyond
Переглядів 274 місяці тому
Expert allergist, Dr Antonella Cianferoni, shares her insights on the latest guidance for the diagnosis and management of food allergies, including the role of novel diagnostic tools and emerging therapies in clinical practice Watch now: touchimmunologyime.org/expert-insights-in-food-allergy-considerations-for-diagnosis-and-management-in-primary-care-and-beyond/ This activity is funded by an in...
Diagnosing and treating patients with EoE: Tackling the difficulties
Переглядів 944 місяці тому
What are the latest advances in the diagnostic and treatment landscape for eosinophilic oesophagitis? Experts Dr Efrem Eren, Dr Nirmala Gonsalves and Dr Jamal Hayat highlight current and future diagnostic and treatment approaches and offer their clinical insights on how these advances may impact future care. touchimmunologyime.org/eoe-diagnosis-treatment/ This activity is funded by an independe...
Addressing the diagnosis and management of pet allergies in primary care and beyond
Переглядів 424 місяці тому
In this focused interview, Dr Ann-Marie Schoos answers a series of questions on the diagnosis and management of pet allergies, including the role of component-resolved diagnostics in identifying specific IgE responses to specific molecular targets. Watch now: touchimmunologyime.org/diagnosis-and-management-furry-pet-allergy This activity is funded by an independent medical education grant from ...
The rationale for protein degradation and immunomodulation in RRMM: Latest data and clinical trials
Переглядів 534 місяці тому
What are the limitations of current therapies for the treatment of relapsed/refractory multiple myeloma and what is the latest evidence for emerging therapies targeting protein degradation and immunomodulation? Prof. Cristina Gasparetto, Prof. Sagar Lonial and Prof. Sundar Jagannath share their insights. Watch now: touchoncologyime.org/protein-degradation-and-immunomodulation-in-rrmm/ This acti...
Establishing treatment and care pathways for patients with prurigo nodularis:A patient-centric focus
Переглядів 1484 місяці тому
Establishing treatment and care pathways for patients with prurigo nodularis:A patient-centric focus
Addressing challenges in diagnosis and treatment of IgG4-related gastrointestinal disease
Переглядів 3704 місяці тому
Addressing challenges in diagnosis and treatment of IgG4-related gastrointestinal disease
Is HER2 targeting on the horizon in urothelial carcinoma?
Переглядів 525 місяців тому
Is HER2 targeting on the horizon in urothelial carcinoma?
Managing the practicalities of CAR T-cell therapies in patients with R/R MCL
Переглядів 1315 місяців тому
Managing the practicalities of CAR T-cell therapies in patients with R/R MCL
New horizons in R/R follicular lymphoma: risk stratification & practicalities of CAR T-cell therapy
Переглядів 2145 місяців тому
New horizons in R/R follicular lymphoma: risk stratification & practicalities of CAR T-cell therapy
Overcoming challenges in advanced or metastatic squamous cell lung cancer: Focus on immunotherapy
Переглядів 3165 місяців тому
Overcoming challenges in advanced or metastatic squamous cell lung cancer: Focus on immunotherapy
touchIME is proud of the way we're reshaping the continuing education landscape!
Переглядів 375 місяців тому
touchIME is proud of the way we're reshaping the continuing education landscape!
Guideline-based treatment of recurrent/metastatic cervical cancer
Переглядів 3456 місяців тому
Guideline-based treatment of recurrent/metastatic cervical cancer
Advances in IOL technology and power calculations: Updates and innovations
Переглядів 426 місяців тому
Advances in IOL technology and power calculations: Updates and innovations
IgG4-related disease: How to identify, diagnose and treat
Переглядів 6 тис.6 місяців тому
IgG4-related disease: How to identify, diagnose and treat
Paediatric atopic dermatitis: Evolving strategies for improved management
Переглядів 646 місяців тому
Paediatric atopic dermatitis: Evolving strategies for improved management
Optimizing the management of patients with relapsing forms of MS
Переглядів 596 місяців тому
Optimizing the management of patients with relapsing forms of MS
Cataract surgery and ocular comorbidities: Key considerations for IOL choice
Переглядів 666 місяців тому
Cataract surgery and ocular comorbidities: Key considerations for IOL choice
PSMA-targeted radiopharmaceuticals: An evolving approach to prostate cancer management
Переглядів 2477 місяців тому
PSMA-targeted radiopharmaceuticals: An evolving approach to prostate cancer management
Clinical care pathway for Alzheimer’s disease: Driving improvements in diagnosis
Переглядів 887 місяців тому
Clinical care pathway for Alzheimer’s disease: Driving improvements in diagnosis
He didn't check the airway 1st...important step for infants that can put objects in mouth!
Is anyone working on Metabolic therapy for renal cancer? If not, why not?
09
Hi Dr Namita Sood its me Belinda ur past patient from OSU hospital! U look great! Thank you for everything! ❤ Lots of hugs & kisses!!
Would it be possible to have the link to the slides presented?
It’s honestly amazing that a human figured out how to do this. How to manually keep a body alive.
I've had the 6 infusions of the cocktail of Carbo, Taxol, Avastin and keytruda beginning in October of 2023. Mine shrunk from 9.5 to 4.4. I have been on Avastin and Keytruda since for "maintenance". However, I asked for, and received, a biopsy that showed squamous cell still. What do I do now? I have not had radiotherapy or brachy yet. Please and thank you.
In addition to this horrible disease, I can't stand these scents from Foreigners taking away all the America college seats. Fuck globalism ... and this impossible accent
For infants / toddlers that are choking , use a device called the Life-Vac !
Thank you for this great talk
Hello, I saw this very interesting material, I would like you to help me too, please. I have a little boy with hemoliptic anemia due to pyruvate kinase deficiency. please, where can I get the link?
I’m in the uk and the ‘ igg4 specialist ‘ dr George Webster here won’t assist me as my blood results don’t show high igg4 levels but but histology does show igg4 albeit not over the diagnostic threshold but the storiform fibrosis pattern, the lymphocytic infiltrate and others is present - because of this he won’t help me . Ive already had my left submandibular gland excised due to a mass last year, eus of pancreas as I had a mass, lesions and obliterated distal duct and now this week I’ve had an ultrasound of my neck and now my right submandibular gland has an igg4 mass according to my report What do I do because I feel constantly unwell and the uk dr won’t help me he’s so fixated on the igg4 levels and that’s it
Have you been vaccinated with a mRNA vaccine? If so; 1: Which one? 2: Did you take it before or after being naturally infected with Covid? 3: Have you had any boosters if so how many? Studies are showing that vaccination before natural infection creates an igG4 spike, where it is dominant over all other igG subclasses for an extended period.
Please could alleviate my concerns? Your excellent video causes me to ask the following questions. Is this relevant to the IgG-4 class shift after mRNA booster shots? Due to the indolent nature of IgG-4 related disease, could we, potentially ,slowly see a massive increase in this disease over the next few years? How long before anyone can say it is or is not a problem?
ua-cam.com/users/shortsNgs26OeSWfc?si=gZDvLpvOkLnoTdxp
Look up Mero genomics. Delete the gap in that name. My replies being deleted.
@@Ikr2025 good advice !
Yes. I know a case of exactly that. Two weeks after the second double dose of a booster mRNA/Moderna (double because the patient was diabetic, hence CDC recommendation to double booster), the patient was hospitalized, and Type-1 Pancreatitis diagnosed.
I need help getting Treatment with my igg4 and igg2 results. I have autoimmune. Constantly have sinus and ear infections seems like im always sick. Rheumatologist told me that she can't treat me. I need to see an immunologist. Cant find immunologist to treat the igg4.
Hi 👋 how high is your igg4? Did you had biopsy
Get that ad out of here
How to participate for trials? I'm 25 years old and i have lost vision over 80% kindly help me is there any way to participate in clinical trials
Elevated IgG response after PEGylated injectables. (Covid Mrna vaccines are PEGylated.) ua-cam.com/video/eHWdAu-dK9g/v-deo.htmlsi=GMl_lefnsFMiUcWt
I don’t ever get ads Everyone talking about ads like it’s that important Yikes
Covid vaccination
Great video and hope! My brother is 41 years old and has been diagnosed with RP for more than 20 years now. How can we get access to this novel therapy? Thank you
Im very happy to notice that they took down the ads, thank you! That probably saved a few lives
Is the covid vaccine causing this?
There is a child in Assiut Egypt, who has traveled to Cairo to under go diagnostic procedures, i.e. MRI, Long EEG, to conclude the diagnosis of Tuberous Sclerosis Complex. He also has a benign tumor in the brain which needs to be excised. We are wondering if it would behoove the long-term treatment of this 2 1/2 year old in the USA at a center who are at the cutting edge of TSC treatment. Thank you
You each have further inspired me to study dermatology formally (despite my current ordeal); I'll find a way.
Thank you, Sailaja, you're doing amazing work !
Wow
Vielen Dank für das hochladen. Es sind wertvolle Informationen für mich 🙏
This was very helpful information. Great presentation 👏 ❤
I think it is worth pointing out that you had said IDS/NAC is worse than PDS via GORILLA-3004. Which states this is true for non-BRCAm patients. In BRCAm patients, the only independent risk factor found was CA-125>26/4U/mL. Just saying the blanket statement in the video is a bit misleading.
Do you do compressions over pad?
How would one go about becoming a candidate for radiopharmaceutical treatment of prostate cancer?
It will be dependent on the status of your cancer, among other health and logistical parameters. I don't mean to be vague, but there are many things to consider. Talk to your oncology team (if it is you that you are asking about), they will be able to help educate you and give you direction. This is a very good presentation and their excitement for the future of these treatments is real. best wishes, from a radiopharmacist.
Does it really matter as the treatments are mostly the same. I refuse to have a bone marrow aspiration. They are saying MDS but treatment seems the same. I would never consider a BMT so just treat as things come up. For now I have low white and platelets and reds are about to go below normal. I don’t see treatments very different
Cognitive impairment wears off after testosterone recovers after ADT CESSATION??? You obfuscate the fact that after 18 months on ADT CASTRATION, only twenty five percent of patients will recover their testosterone levels after a median time of FIVE YEARS. Seventy five percent will not recover their normal testosterone even after a median time of five years. Get the truth out, not more of big pharma sales propaganda. You obfuscate the facts.You coerce, deceive, and intimate patients into ADT CASTRATION without full disclosure and therefore WITHOUT FREE AND FULLY INFORMED CONSENT
1 do recommend Dr.Ogoh Herbs for hpv he cured me and my partner I am glad to have came across his UA-cam channel..❤ 0:10
1 do recommend Dr.Ogoh Herbs for hpv he cured me and my partner I am glad to have came across his UA-cam channel.. 0:10
Is this caused by mold toxicity? Strep? Staph ?
Nobody knows yet, by what IGG4-RD is caused. In my case I would say stress and trauma - but there is no definite answer. But as not everyone who has to deal with mold in their appartment has IGG4-RD I would say it's more of a risk factor - if anything.
Jab
All of those potentially my understanding which is rudimentary, this is the body off switch to immune system, the way we develop tolerance to antigens
SHARED DECISION MAKING????? At the CROSS CANCER INSTITUTE, I was given no say at all in my prostate cancer treatment. When I expressed my concern about the 6 month shot of Eligard ADT CASTRATION because it would be irreversible if I encountered adverse reactions.... My dictator doctor barked..U WON'T LET YOU OFF IT FOR AT LEAST A YEAR. More like concentration camp treatment than shared decision making. Patients are handled like sheep herded into a meat processing plant. Untimidated by fear into a cruel and barbaric treatment, and denied full disclosure about the benefits and the horrific quality of life destroying and life threatening side effects. Give men back control over their own bodies and lives. make treatment decisions together. Then men will feel some control and ownership in their treatment, and be better able to ride out the rough journey through the side effects. I hope this lesson can be learned by all doctors treating prostate cancer.
SUBOPTIMAL EDUCATION???? Doctors need to be properly educated about the true benefits and horrific side effects of the medications they prescribe. Dr. John Mulhall says doctors dish out ADT like water, without giving full disclosure of the horrific side effects and without getting FREE AND FULLY INFORMED CONSENT. Doctors parrot the big pharma sales propaganda promoting these outrageously expensive toxins, and obfuscate and deceive men about the horrific side effects. Patients are rarely warned that ADT CASTRATION has very long term effects, and can result in permanent CASTRATION in up to twenty percent of older men. Doctors are castrating men with no more ethics than NAZI doctors in the concentration camps. It's not just unethical, it is criminal.
Treatment compliance???? When patients are coerced, deceived, intimidated and extorted into ADT CASTRATION without FULL DISCLOSURE of ALL the horrific quality of life destroying and life threatening side effects of this cruel and barbaric treatment, there has been no FREE AND FULLY INFORMED CONSENT. When patients experience the truth, or discover that they have been duped, they lose trust and respect in their doctors and medical teams. The lasting effects of ADT are so long term that missing a couple of months before getting the next shot of these toxins is insignificant because the testosterone levels remain well below castrate level for months or years . Delaying the next ADT shot harms noone except the big pharma shareholders who make outrageous profits exploiting vulnerable patients. Please warn your patients that testosterone recovery is undetermined after ADT, and up to twenty percent of older men will NEVER RECOVER their testosterone levels above castrate level.
ONCE TESTOSTERONE RECOVERS?????? Why the deception and obfuscation regarding testosterone recovery after ADT CASTRATION treatment ceases???? You falsely imply that everything returns to normal and the horrific quality of life destroying and life threatening side effects of this ADT CASTRATION cruel and barbaric treatment cease after completion of treatment. Tell the truth that after 6 months of ADT Leuoprolide treatment, only 75 percent of men will recover their testosterone levels after a median time of 18 months. ....... After 18 months or more on ADT, only 25 percent of men will recover their testosterone levels after a median time of five years. So, tell the truth... After men are coerced, deceived, and extorted into these toxic injections, 75 percent of men will NOT RECOVER even after FIVE YEARS. WARNING....up to twenty percent of older men will NEVER RECOVER ABOVE CASTRATE LEVEL and suffer the rest of their miserable lives as ZOMBIE EUNUCHS.
グアニル酸シクラーゼ活性を利用する一回膜貫通型受容体にはANP受容体が挙げられますよね。ANPの受容によって細胞内でGTPからcGMPを合成し、そのcGMPがPKCやホスホジエステラーゼを活性化して細胞内でのシグナル伝達を開始する。
Thanks for uploading.
I'd say over half the population now have igG4 antibodies after the rollout of mRNA shots. What is the medical community doing with this? The corticosteroids available all seem to have more risk than benefit taking. Post -Covid I think the entire medical establishment is going to fall apart. Very few people are trusting medical " Professionals " anymore. We'd rather die than take your snake oil that you push on your fellow human beings in the name of profit. There's a special place in hell waiting for you people.
Dear Dr. Julie, how to contact you or your hospital ? We are trying to reach from Nepal 🇳🇵
would it help for CRVO for 1 eye which was in April 2023... my VA is like 20/200
Pleasure to meet you at HFSA in Cleveland! I was one of the Abbott LVAD ambassadors!
DR. Sallman speaks too quickly! It was disturbing to listen to him.
Why we need 5 rescue breath first before starting to give chest compression?thank you
The introduction is repeated three times then it stops. How is this helpful? Quality control?
Please help me sir my mom NMO problem😢